These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35855033)

  • 1. A retrospective study of 43 cases of fungal malignant external otitis.
    Halwani C; Mtibaa L; Hamdi ME; Baccouchi N; Benmhamed R; Jemli B; Akkari K
    Pan Afr Med J; 2022; 41():287. PubMed ID: 35855033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Identification and Antifungal Susceptibility of Yeasts and Molds Isolated from Patients with Otomycosis.
    Kiakojuri K; Mahdavi Omran S; Roodgari S; Taghizadeh Armaki M; Hedayati MT; Shokohi T; Haghani I; Javidnia J; Kermani F; Badali H; Abastabar M
    Mycopathologia; 2021 May; 186(2):245-257. PubMed ID: 33718990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Agents of otomycosis in Manisa region, Turkey, 1995-2011].
    Değerli K; Ecemiş T; Günhan K; Başkesen T; Kal E
    Mikrobiyol Bul; 2012 Jan; 46(1):79-84. PubMed ID: 22399174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Otomycosis: The foremost aetiological agent causing otitis externa and the antifungal susceptibility pattern in North-Western Iran.
    Roohi B; Nemati S; Alipour A; Faeli L; Mayahi S; Haghani I; Shalchizadeh M; Darini A; Al-Hatmi AMS; Abastabar M; Shokohi T
    Mycoses; 2023 Feb; 66(2):87-97. PubMed ID: 36134511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
    Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of fungal otitis externa caused by coinfection of Candida auris and Aspergillus flavus.
    Ito Y; Inoue N; Kaneko N; Otsuka M; Yamasaki S; Yoshikawa M
    J Infect Chemother; 2023 Aug; 29(8):809-811. PubMed ID: 37094768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
    Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
    Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fungal necrotizing external otitis: diagnosis, management and outcomes of 15 cases.
    Korbi AE; Houas J; Kolsi N; Bouatay R; Ferjaoui M; Toumi A; Harrathi K; Koubaa J
    Pan Afr Med J; 2022; 42():306. PubMed ID: 36425541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otomycosis: Diagnosis and treatment.
    Vennewald I; Klemm E
    Clin Dermatol; 2010 Mar; 28(2):202-11. PubMed ID: 20347664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
    Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
    J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular identification and antifungal susceptibilities of black Aspergillus isolates from otomycosis cases in Hungary.
    Szigeti G; Kocsubé S; Dóczi I; Bereczki L; Vágvölgyi C; Varga J
    Mycopathologia; 2012 Aug; 174(2):143-7. PubMed ID: 22359155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the Vitek 2 yeast susceptibility test and CLSI broth microdilution reference method for testing antifungal susceptibility of invasive fungal isolates in Italy: the GISIA3 study.
    Borghi E; Iatta R; Sciota R; Biassoni C; Cuna T; Montagna MT; Morace G
    J Clin Microbiol; 2010 Sep; 48(9):3153-7. PubMed ID: 20631105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran.
    Gharaghani M; Halvaeezadeh M; Ali Jalaee G; Taghipour S; Kiasat N; Zarei Mahmoudabadi A
    Curr Med Mycol; 2020 Jun; 6(2):18-22. PubMed ID: 33628977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fungal otitis externa in children: principles of diagnosis and rational therapy].
    Kryukov AI; Kunelskaya NL; Kunelskaya VY; Ivoylov AY; Shadrin GB; Machulin AI
    Vestn Otorinolaringol; 2020; 85(1):60-63. PubMed ID: 32241991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.
    Lass-Flörl C; Mayr A; Perkhofer S; Hinterberger G; Hausdorfer J; Speth C; Fille M
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3637-41. PubMed ID: 18694949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents.
    Giacobino J; Montelli AC; Barretti P; Bruder-Nascimento A; Caramori JT; Barbosa L; Bagagli E
    Med Mycol; 2016 Oct; 54(7):725-732. PubMed ID: 27143636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Fungal Pathogens in Otomycosis and Their Drug Sensitivity: Our Experience.
    Ali K; Hamed MA; Hassan H; Esmail A; Sheneef A
    Int Arch Otorhinolaryngol; 2018 Oct; 22(4):400-403. PubMed ID: 30357045
    [No Abstract]   [Full Text] [Related]  

  • 20. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.